Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
EXACT Sciences Corporation
State Mandates for Stool-Based DNA Screening for Colon Cancer now in Twelve States and the District of Columbia
January 25th, 2009
EXACT Sciences Corporation (NASDAQ: EXAS) reported that as of January 1, 2009, twelve states and the District of Columbia have legislative mandates requiring that available colorectal cancer (CRC) screening options offered by certain categories of insurers in these states must include all tests identified in the current American Cancer Society (ACS) screening guidelines, which include stool-based DNA (sDNA) screening. The state of Maine, which enacted a legislative mandate covering colorectal cancer screening effective on January 1, 2009, has become the latest state to explicitly reference CRC screening guidelines, which include sDNA testing. The list now includes...
Source: Pharma Investments, Ventures & Law Weekly (2009-01-25)
|
